Literature DB >> 6342884

Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.

R T Dean, J L Virelizier.   

Abstract

The cytolytic activity of human peripheral blood monocytes in vitro against K-562 human leukaemic target cells was stimulated by human fibroblast (beta-) and leucocyte (alpha-) interferon (IFN). Stimulation was by up to several times the corresponding control activity, and was observed with freshly isolated monocytes, and with monocytes cultured for various periods up to 10 days. The cytolytic activity of untreated monocytes was detectable at very low effector: target ratios (less than 5:1), and fell between days 1 and 4 in culture, normally rising again towards the initial activity at day 8; this pattern was also observed when IFN was present continuously, although the activities were then always higher than in the corresponding control cells. Cytolysis showed a lag of about 6 hr, in contrast to that by natural killer (NK) cells, and was routinely measured over 24 hr. The course of stimulation by IFN and its dose-response were studied. Stimulation required the presence of IFN for at least 24 hr, and was maximal with between 1,000 and 10,000 units of IFN/ml. When IFN containing media were removed and replaced with control media, the monocyte activity remained stimulated for at least 4 days. Stimulation by beta-IFN was blocked by a specific antibody to beta-IFN, under conditions in which assayable IFN activity was also neutralized. Several control experiments indicated that the action of IFN was on the monocytes and not on the target cells. The morphological maturation of monocytes was retarded by IFN, even in cultures containing up to 50% serum. The effectiveness of fibroblast IFN indicated that stimulation could not be attributed to the lymphokines which might contaminate alpha-IFN. The action of IFN did not require simultaneous or antecedent in vitro stimulation by endotoxin. This was indicated both by serum free experiments, and also by others in which polymixin B was used to complex with and render unavailable any endotoxin present. Endotoxin showed an independent stimulatory effect, which could be prevented by polymixin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6342884      PMCID: PMC1536799     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  20 in total

1.  Production by mixed lymphocyte cultures of a type II interferon able to protect macrophages against virus infection.

Authors:  J L Virelizier; A C Allison; E de Maeyer
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

2.  Interferons and the immune system.

Authors:  B R Bloom
Journal:  Nature       Date:  1980-04-17       Impact factor: 49.962

3.  Functional and morphologic characteristics of interferon-treated macrophages.

Authors:  R M Schultz; M A Chirigos; U I Heine
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

4.  Spontaneous and induced cytotoxic properties of human adherent mononuclear cells: killing of non-sensitized and antibody-coated non-erythroid cells.

Authors:  D A Horwitz; N Kight; A Temple; A C Allison
Journal:  Immunology       Date:  1979-02       Impact factor: 7.397

5.  Human adherent mononuclear blood cells: cytolytic and cytostatic activity and characterization of effector cells during in vitro culture.

Authors:  J Hammerstrøm
Journal:  Acta Pathol Microbiol Scand C       Date:  1981-04

6.  Induction of macrophage lysosomal enzyme secretion by agents acting at the plasma membrane.

Authors:  R T Dean; W Hylton; A C Allison
Journal:  Exp Cell Biol       Date:  1979

7.  In vitro influence of endotoxin on human mononuclear phagocyte structure and function. 2. Enhancement of the expression of cytoststic and cytolytic activity of normal and lymphokine-activated monocytes.

Authors:  J Hammerstrøm
Journal:  Acta Pathol Microbiol Scand C       Date:  1979-12

8.  Human monocyte-mediated cytotoxicity to K-562 cells: activation by lymphokines.

Authors:  J Hammerstrøm
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

9.  Persistent Epstein-Barr virus infection in a child with hypergammaglobulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion.

Authors:  J L Virelizier; G Lenoir; C Griscelli
Journal:  Lancet       Date:  1978-07-29       Impact factor: 79.321

10.  Extracellular cytolysis by activated macrophages and granulocytes. I. Pharmacologic triggering of effector cells and the release of hydrogen peroxide.

Authors:  C F Nathan; L H Brukner; S C Silverstein; Z A Cohn
Journal:  J Exp Med       Date:  1979-01-01       Impact factor: 14.307

View more
  11 in total

1.  Identification of a human non-interferon lymphokine activating monocyte complement biosynthesis.

Authors:  C Drouet; A Reboul; M Colomb
Journal:  Biochem J       Date:  1989-10-01       Impact factor: 3.857

2.  Interferon-alpha induction of lymphocytes containing parallel tubular structures.

Authors:  Y L Hoogeveen; J W Smit; N R Blom; M J van Luyn; R M Halie
Journal:  Blut       Date:  1988-02

3.  Natural killer cells and spontaneous cell-mediated cytotoxicity in the human intestine.

Authors:  P R Gibson; E L Dow; W S Selby; R G Strickland; D P Jewell
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

Review 4.  Macrophage-directed lymphokines.

Authors:  D Y Liu
Journal:  Surv Immunol Res       Date:  1984

5.  The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis.

Authors:  G A Rook; J Taverne; C Leveton; J Steele
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

6.  Induction of antitumor activity in macrophages by mycoplasmas in concert with interferon.

Authors:  K Uno; M Takema; S Hidaka; R Tanaka; T Konishi; T Kato; S Nakamura; S Muramatsu
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Inhibitory versus stimulatory effects of natural human interferon-alpha on proliferation of lymphocyte subpopulations.

Authors:  V Holán; S Nakamura; J Minowada
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

8.  Human tumour-induced inhibition of interferon action in vitro: reversal of inhibition by beta-carotene (pro-vitamin A).

Authors:  J Rhodes; P Stokes; P Abrams
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  Efficient activation of human blood monocytes to a tumoricidal state by liposomes containing human recombinant gamma interferon.

Authors:  W C Koff; W E Fogler; J Gutterman; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

10.  Tumor cytotoxicity of human monocyte membrane-bound interleukin-1 alpha induced by synergistic actions of interferon-gamma and synthetic acyltripeptide, FK-565.

Authors:  N Inamura; S Sone; A Okubo; E Kunishige; M Nakanishi; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.